- Home
- RLAY vs KRMD Comparison
RLAY vs KRMD Comparison
Compare RLAY & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- KRMD
- Stock Information
- Founded
- RLAY 2015
- KRMD 1980
- Country
- RLAY United States
- KRMD United States
- Employees
- RLAY N/A
- KRMD N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- KRMD Medical/Dental Instruments
- Sector
- RLAY Health Care
- KRMD Health Care
- Exchange
- RLAY Nasdaq
- KRMD Nasdaq
- Market Cap
- RLAY 576.1M
- KRMD 134.3M
- IPO Year
- RLAY 2020
- KRMD N/A
- Fundamental
- Price
- RLAY $3.63
- KRMD $3.22
- Analyst Decision
- RLAY Strong Buy
- KRMD Strong Buy
- Analyst Count
- RLAY 11
- KRMD 4
- Target Price
- RLAY $18.40
- KRMD $4.63
- AVG Volume (30 Days)
- RLAY 1.5M
- KRMD 450.7K
- Earning Date
- RLAY 08-05-2025
- KRMD 08-06-2025
- Dividend Yield
- RLAY N/A
- KRMD N/A
- EPS Growth
- RLAY N/A
- KRMD N/A
- EPS
- RLAY N/A
- KRMD N/A
- Revenue
- RLAY $7,679,000.00
- KRMD $35,083,740.00
- Revenue This Year
- RLAY $17.59
- KRMD $18.16
- Revenue Next Year
- RLAY N/A
- KRMD $14.60
- P/E Ratio
- RLAY N/A
- KRMD N/A
- Revenue Growth
- RLAY N/A
- KRMD 19.65
- 52 Week Low
- RLAY $1.78
- KRMD $1.86
- 52 Week High
- RLAY $10.72
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- RLAY 57.25
- KRMD 42.70
- Support Level
- RLAY $3.50
- KRMD $3.54
- Resistance Level
- RLAY $3.86
- KRMD $3.80
- Average True Range (ATR)
- RLAY 0.18
- KRMD 0.23
- MACD
- RLAY 0.02
- KRMD -0.04
- Stochastic Oscillator
- RLAY 65.79
- KRMD 7.63
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).